Risk factors for MI in three case–control studies Dov Shiffman John P. Kane Judy Z. Louie Andre R. Arellano David A. Ross Joseph J. Catanese Mary J. Malloy Stephen G. Ellis James J. Devlin 10.1371/journal.pone.0002895.t001 https://plos.figshare.com/articles/dataset/_Risk_factors_for_MI_in_three_case_8211_control_studies_/594631 †<p>Data available for 254 cases.</p>‡<p>Individuals with diabetes were excluded from control group.</p>§<p>Dyslipidemia was defined in Study 1 and Study 2 to be self-reported history of a physician diagnosis of dyslipidemia or the use of lipid lowering prescription medication(s) and defined in Study 3 to be the use of lipid lowering prescription medication(s), LDL cholesterol >129 mg/dL, triglycerides >149 mg/dL or HDL cholesterol <45 mg/dL .</p>||<p>Hypertension was defined in Study 1 and Study 2 to be a self–reported history of a physician diagnosis of hypertension or use of antihypertensive prescription medication(s) and defined in Study 3 to be the use of antihypertensive prescription medication(s), systolic blood pressure >160 mmHg, or diastolic blood pressure >90 mmHg.</p><p>NA; not applicable.</p> 2013-02-21 09:45:58 mi